Status:
COMPLETED
Website Smoking Cessation Intervention for the Promotion of Smoking Cessation in Low-Income Veterans
Lead Sponsor:
Fred Hutchinson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Cigarette Smoking-Related Carcinoma
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
This phase I trial studies how well a new electronic (e)-health smoking cessation program (called Vet Flexiquit) works in promoting smoking cessation in low-income veterans who may or may not be ready...
Detailed Description
OUTLINE: Participants are randomized to 1 of 2 arms. ARM I: Participants use the new website smoking cessation program, which provides values driven, mindfulness based coping skills and utilizes non-...
Eligibility Criteria
Inclusion
- Participants must be a US veteran
- Participants must be low-income, as defined by falling below Veterans Health Administration (VHA) national income threshold for no-cost healthcare
- Participants must be a current smoker, averaging at least 5 cigarettes/day for the last 30 days
- Participants must have weekly internet access for the next 3 months
- Participants must self-report current use of a personal email address to receive the link to their assigned web site
- Participants must self-report being willing to complete all study activities
- Participants must be willing to receive study-related text messages
Exclusion
- Currently taking part in any other smoking cessation treatment such as the nicotine patch, nicotine gum, Zyban, in-person counseling, telephone counseling, using a web-based or app-based cessation program
- Have recent (past 30 days) substance use disorder, suicidal ideation, or psychiatric hospitalization
- Previous participation in the treatment development stage of the new smoking cessation website program
- Prior use of the SmokefreeVET web site
- Member of the same household as another research participant
- Woman who is pregnant or breastfeeding, or planning to become pregnant
Key Trial Info
Start Date :
February 3 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 28 2022
Estimated Enrollment :
53 Patients enrolled
Trial Details
Trial ID
NCT04502524
Start Date
February 3 2021
End Date
January 28 2022
Last Update
April 7 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Bedford VA Research Corporation, Inc.
Bedford, Massachusetts, United States, 01730